1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Interojo Inc.

Interojo Inc.

KKRX:119610
15,050.00
KRW
-690.00
(-4.38%)
1,429.47EPS
12.82P/E
205.94BMarket Cap
Nov 18Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3,298.12
3,739.66
4,887.9
6,039.03
6,672.24
6,511.38
7,689.04
7,476.4
8,795.66
9,302.64
9,553.88
9,426.36
9,218.62
10,923.5
Basic EPS, GAAP
742.39
606.05
1,033.54
1,585.05
1,595.22
1,196.73
1,458.21
978.43
1,206
1,472
253
15
1,007
1,429.31
Free Cash Flow per Basic Share
91.25
289.67
649.79
753.5
472.01
-356.2
621.7
-812.82
248.84
-415.33
17.47
1,340.5
1,433.18
1,417.32
Dividend per Share
61.56
61.65
61.27
105.64
159.5
259.15
272.26
281.77
274.06
442.93
598.94
610.84
292.63
- -
Book Value per Share
4,533.97
5,050.52
6,064.63
7,447.01
8,716.59
10,257.6
11,292.32
11,844.19
13,889.49
14,384.65
14,141.31
13,561.49
13,977.91
13,645.81
Tangible Book Value per Share
4,510.02
5,013.23
6,030.48
7,384.19
8,643.1
10,163.55
11,200.33
11,747.96
13,809.35
14,313.67
14,029.89
13,463.6
13,880.2
13,553.49
Basic Weighted Avg Shares
12
12
12
12
12
12
12
12
12
13
12
12
13
12
Sales/Revenue/Turnover
40,128
45,435
59,558
73,714
80,618
79,428
92,569
88,203
107,535
117,822
119,297
115,840
118,440
126,030
Operating Margin (%)
26.25
19.3
27.35
31.62
30.06
21.56
24.43
17.17
21.05
20.52
4.35
5.02
16.45
18.67
Depreciation Expense
3,069
3,300
3,744
4,204
4,493
4,861
6,459
7,706
8,631
9,250
9,596
10,197
9,967
9,992
Net Income, GAAP
9,033
7,363
12,593
19,348
19,274
14,598
17,555
11,543
14,744
18,644
3,159
184
12,938
16,491
Effective Tax Rate (%)
17.15
16.31
18.34
19.17
20.17
18.69
20.34
23.61
30.29
13.83
- -
89.48
16
18.49
Profit Margin (%)
22.51
16.21
21.14
26.25
23.91
18.38
18.96
13.09
13.71
15.82
2.65
0.16
10.92
13.08
Working Capital
23,513
29,926
34,200
46,234
56,206
67,183
63,994
49,444
84,322
61,463
67,334
64,567
91,178
88,270
LT Debt
2,750
4,754
3,893
- -
- -
4,000
4,441
3,928
15,087
4,463
9,822
446
616
625
Total Equity
55,154
61,241
74,084
90,644
102,375
121,275
131,457
134,929
173,180
179,306
176,914
169,942
157,029
153,301
Return on Invested Capital (%)
14.89
11.26
17.63
21.09
19.14
11.93
12.86
7.28
8.72
9.99
- -
0.3
9.03
10.31
Return on Capital (%)
15.94
11.66
17
22.15
19.44
12.67
13.06
7.55
8.49
9.34
- -
0.25
7.83
9.74
Return on Common Equity (%)
17.73
12.65
18.61
23.49
19.97
13.05
13.89
8.67
9.57
10.58
1.77
0.11
7.91
10.28

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
35,189
25,242
25,223
LT Borrowings
- -
- -
- -
LT Finance Leases
324
616
625
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
205,562
179,876
205,941

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
118,603
147,996
155,692
Cash, Cash Equivalents & STI
6,533
32,634
37,442
Accounts Receivable, Net
60,061
61,203
60,097
Inventories
42,861
43,667
47,929
Total Current Liabilities
64,440
56,819
67,422
Payables & Accruals
- -
- -
- -
ST Debt
35,189
25,242
25,223
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.38%
3.8%
-7.6%
Free Cash Flow
625.82%
1,391.32%
11.78%
Net Income, GAAP
681.06%
1,359.12%
6,918.66%
Sales/Revenue/Turnover
7.56%
6.42%
2.24%
Total Cash Common Dividend
24.33%
10.4%
-49.92%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
33,635
26,644
33,097
23,790
115,840
2025
23,126
31,336
32,354
31,624
118,440
2026
30,716
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
300
-138
299
-401.68
15
2025
113
285.16
335.35
373.42
1,007
2026
441.82
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
610.84
2025
- -
- -
- -
- -
292.63
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Si-Chul No
Full Time Employees
735
Sector
Health technology
Industry
Medical specialties
Address
28&25 Sandan-ro Pyeongtaek-si GG South Korea 13486
IPO Date
Jul 28, 2010
Website
interojo.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Interojo Inc. (119610.KQ) manufactures and sells contact lenses in South Korea and internationally. The company offers silicone hydrogel lenses, premium hydrogel lenses, hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses including cosmetic varieties, therapy and bandage lenses, rigid gas permeable (RGP) contact lenses, and solutions; its product line encompasses daily disposable, monthly disposable, and colored cosmetic contact lenses, with OEM/ODM services for global brands and proprietary brands like Clalen. Founded in 2000 and headquartered in Pyeongtaek-si, Gyeonggi-do, South Korea, Interojo operates manufacturing facilities including a first factory, second factory, and third S-Plant, with a Seoul office and a China branch office, serving domestic and overseas markets through a digital cross-border supply chain compliant with regulations such as FDA, CE, and CFDA. Recent developments include the launch of Clalen O2O2 1day Toric, a silicone hydrogel daily disposable toric lens, in May 2024; receipt of the $70 million Export Tower Award from the Korea Trade Association in December 2023; recognition as a venture company with over 100 billion won in sales for consecutive years in 2022; and the launch of Clalen O2O2 Color 1day Toric, a silicone hydrogel color daily disposable toric lens, in September 2022.